Longitudinal cognitive changes in patients with early Parkinson's disease and neuropsychiatric symptoms
CNS Neuroscience & Therapeutics · 2023-08 · 29 (8) · 2259-2266
DOI: 10.1111/cns.14173 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 16.03.2023. Verfasst von Detao Meng und 3 weiteren Autor:innen. Beteiligte Einrichtung: Parkinson Medical Center, Beijing Rehabilitation Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Parkinson Disease, Cognitive Dysfunction, Apathy, Psychotic Disorders. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Aims
In this study, we aimed to investigate the effect of neuropsychiatric symptoms (NPS) on the rate of cognitive decline for both global cognition and specific cognitive domains in a cohort of patients from the Parkinson's Progression Markers Initiative (PPMI).
Method
Prospectively longitudinal data were obtained from the PPMI cohort. NPS, including depression, anxiety, apathy, psychosis, impulse control disorders (ICDs), and cognition ability, were evaluated by a series of questionnaires. Linear mixed‐effects models were used to investigate the relationship between NPS and the rate of cognitive decline. Generalized estimating equations (GEEs) were used to investigate the relationship between NPS and the occurrence of mild cognitive impairment (MCI).
Results
In total, 423 patients with Parkinson's disease (PD) were recruited at baseline and 395, 378, 366, 346, and 315 participants were followed up at 1, 2, 3, 4, and 5 years, respectively. Depression, anxiety, apathy, and psychosis were associated with global cognitive decline. Except for those with ICDs, patients with psychosis, depression, anxiety, and apathy were more likely to meet the criteria for MCI. Patients with depression and anxiety showed a progressive decline in four major cognitive domains. Apathy and ICDs were separately associated with a progressive decline in processing speed‐attention and memory, respectively.
Conclusions
Neuropsychiatric symptoms, including psychosis, depression, anxiety, and apathy, could be used to predict future cognitive decline in patients with PD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Parkinson Medical Center, Beijing Rehabilitation Hospital, Capital Medical University, Beijing, China.
ORCID-Profile: Boyan Fang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Meng, D., Jin, Z., Wang, Y., & Fang, B. (2023). Longitudinal cognitive changes in patients with early Parkinson's disease and neuropsychiatric symptoms. CNS Neuroscience & Therapeutics, 29(8), 2259-2266. https://doi.org/10.1111/cns.14173
Vancouver
Meng D, Jin Z, Wang Y, Fang B. Longitudinal cognitive changes in patients with early Parkinson's disease and neuropsychiatric symptoms. CNS Neuroscience & Therapeutics. 2023;29(8):2259-2266. doi:10.1111/cns.14173
BibTeX
@article{Meng2023,
author = {Meng, Detao and Jin, Zhaohui and Wang, Yixuan and Fang, Boyan},
title = {Longitudinal cognitive changes in patients with early Parkinson's disease and neuropsychiatric symptoms},
journal = {CNS Neuroscience & Therapeutics},
year = {2023},
volume = {29},
number = {8},
pages = {2259--2266},
doi = {10.1111/cns.14173}
}
EUVIMED